Malaria Vaccine
Plasmodium falciparum MSP-1 asexual blood stage vaccine is safe and immunogenic
Published in Blood Weekly, June 22nd, 2006
"We report the first safety and immunogenicity trial of the Plasmodium falciparum malaria blood stage vaccine candidate, FMP1/AS02A consisting of the FMP1 antigen, an Escherichia coli-expressed His-tagged fusion protein from the 42 kDa C-terminal fragment from the 3D7 clone of the merozoite surface protein 1 formulated in the AS02A adjuvant," scientists in the United states wrote.
C.F. Ockenhouse and colleagues at Walter Reed Army Institute of Research in Silver Spring conducted an open label, "prospective, single-center Phase 1 dose escalation trial of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-06-22)
More Articles from Blood Weekly
- Blood Banking
New project aims to use genotyping to improve patient safety and blood transfusion compatibility - Blood Banking
Platelet additive solutions offer several advantages for platelet storage - Blood Safety
West Nile Virus safety policy developed by Canadian Blood Services more stringent than U.S. policy - Tissue Engineering
Pre-seeding menisci enhances vascularization and increases extra-cellular matrix - Tissue Engineering
Tissue-engineered bone grafts can be transferred to lesions lacking adequate blood supply - Abdominal Aortic Aneurysms
Endologix receives U.S. Food and Drug Administration approval for Visiflex Delivery System - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
